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Tao Zhang, Veenu Minhas, Charles Wood, 
and Na He
To summarize the seroprevalence of human herpesvi-
rus 8 (HHV-8) in mainland China, we conducted a system-
atic review and meta-analysis based on available literature. 
Data show that differences in HHV-8 prevalence vary con-
siderably among different ethnic groups and geographic re-
gions. Blood-borne transmission could be a potential route 
for HHV-8 infection in China. 
Human herpesvirus 8 (HHV-8) is the infectious etio-logic agent associated with Kaposi sarcoma, primary 
effusion lymphoma, and multicentric Castleman disease. 
Worldwide seroprevalence of HHV-8 varies: generally 
low to moderate for populations in Western countries and 
Asia (1–4) but as high as 50% for the general population 
in sub-Saharan Africa and higher for HIV-positive popu-
lations (5–7). The transmission modes of HHV-8 may also 
differ in different geographic areas and subpopulations; 
sexual and nonsexual transmission have been described 
(8–10). Blood-borne transmission may exist, especially 
among intravenous drug users (IVDUs) and blood recipi-
ents (11).
The Ministry of Health of China, the United Nations 
Program on HIV/AIDS, and the World Health Organiza-
tion estimate that ≈320,000 HIV/AIDS cases have been 
reported in China (12). However, the epidemiologic char-
acteristics of HHV-8 infection, a severe HIV/AIDS oppor-
tunistic infection, have not been well described for China. 
Therefore, we conducted a systematic review and meta-
analysis on the basis of available data for HHV-8 epidemi-
ology from mainland China to have a better understanding 
of the prevalence, variation, and factors associated with its 
transmission.
The Study
A comprehensive literature search of published stud-
ies indexed in global and databases in China during 1995–
2010 was conducted. Initially, 125 reports published in 
English and 223 in Chinese concerning the seropreva-
lence in mainland China were identifi ed. Among them, 85 
articles published in England and 178 articles published 
in China were excluded after title and abstract screening. 
After reading the full text, we excluded another 33 Eng-
lish and 26 Chinese articles. Finally, 26 publications were 
included in this systematic review and have been summa-
rized in online Technical Appendix Table 1 (wwwnc.cdc.
gov/EID/pdfs/10-2070-Techapp.pdf). These studies were 
cross-sectional and were conducted in 8 of the 34 prov-
inces. A substantial number (35.5%) of these studies were 
conducted in the Xinjiang Uygur Autonomous Region. 
Most samples tested were serum or plasma with few ex-
ceptions (1 whole blood, 1 peripheral blood mononuclear 
cells); sample sizes ranged from 37 to 4,461 (median 242, 
interquartile range 199–520). Overall, 18,547 participants 
were involved in the present analysis, and among them 
15,913 were from the general population, 1,970 were im-
munocompromised patients, and 664 were IVDUs. Labo-
ratory methods for all included studies were reported (19 
detected HHV-8 by ELISA, 3 by PCR, and 4 by immuno-
fl uorescent assay.
The prevalence of HHV-8 pooled from reviewed stud-
ies was 11.3% (95% CI 7.2–15.5) for the general popula-
tion, 22.2% (95% CI 12.7–31.8) for immunocompromised 
patients, and 31.2% (95% CI 27.7–34.7) for IVDUs. The 
prevalence among the general population was found to 
be the lowest in Guangdong Province and the highest in 
Xinjiang Province. A similar regional variation was found 
for immunocompromised persons. Among IVDUs, the 
prevalence was 34.3% (95% CI 28.3–40.3) in Zhejiang and 
29.6% (95% CI 25.3–33.9) in Xinjiang Uygur Autonomous 
Region (online Technical Appendix Table 2; Figure).
Five studies, including 4,637 persons of Han ethnic-
ity and 4,011 persons of ethnic minorities (2,040 Uygur, 
1,169 Kazak, 200 Khalkas, 173 Hue, and 429 other) 
conducted in the Xinjiang Uygur Autonomous Region 
were analyzed for association of ethnicity with HHV-8 
prevalence (online Technical Appendix Figure, panel A). 
The risk was signifi cantly lower for the Han group than 
for other ethnic groups (odds ratio [OR] = 0.59, 95% CI 
0.55–0.76). For the Han group, the pooled prevalence of 
HHV-8 in Xinjiang Uygur Autonomous Region was sig-
nifi cantly higher when compared with that for other re-
gions, 14.4% (95% CI 9.0–19.8) versus 6.4% (95% CI 
4.1–8.6). Ten combined studies, with 5,716 male and 
4,708 female participants, respectively, were included 
in meta-analysis of association between sex and HHV-
8 infection (online Technical Appendix Figure, panel B). 
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There was no signifi cant difference between the sexes: 
pooled OR 0.94 (95% CI 0.84–1.04).
Seven studies, with 863 HIV-positive patients and 
3,438 negative controls, were included in the analysis. All 
studies yielded a signifi cant difference in HHV-8 infection 
between HIV-positive and HIV-negative participants; ORs 
for individual studies ranged from 1.50 to 4.27, and the 
pooled OR was 2.97 (95% CI 2.22–3.97) (online Technical 
Appendix Figure, panel C). However, a signifi cant publica-
tion bias was detected (Egger test p = 0.013; Begg test p = 
0.016). A visual inspection of the funnel plot suggested that 
some large or small studies with negative or null results 
were not published (data not shown).
Few studies were designed to address the issue of pos-
sible transmission routes among the population of china. 
Six studies had information on possible blood transmis-
sion. Two blood transfusion studies and 4 studies of IVDUs 
included 837 persons who reported having been exposed 
to blood contact i.e., needle sharing and 1,397 who were 
never exposed (online Technical Appendix Figure, panel 
D). Substantial heterogeneity (I2 87%, p<0.001, by test for 
heterogeneity) was detected among those studies; there-
fore, a random-effects model was used to estimate the OR. 
No publication bias was detected (Begg test p = 0.707; Eg-
ger test p = 0.363). OR showed a marginal association of 
HHV-8 prevalence with blood transfusion (OR 2.01, 95% 
CI 0.89–4.56) for possible blood transmission.
Conclusions
This systematic review indicated that HHV-8 preva-
lence in China varies in different regions. Pooling of data 
from 26 studies provided us with a large sample size, which 
is one of the strengths of the study. Also, we included stud-
ies that were published in the Chinese language and were 
not accessible to the international community. The results 
of this meta-analysis show that HHV-8 prevalence was 
higher in the Xinjiang Uygur Autonomous Region than 
other areas in general and among high-risk populations. 
Historically, Xinjiang Uygur Autonomous Region has been 
regarded as an area in which Kaposi sarcoma is endemic 
(13). Notably, geographic variations of HHV-8 infection 
within China are not well known and need to be investi-
gated as well.
It has been well documented that HHV-8 prevalence 
is higher among HIV-infected persons (14,15). In main-
land China, we found a 3-fold increase in HHV-8 infection 
among persons with HIV compared with HIV-noninfected 
persons. Given the rapid increase of HIV/AIDS cases in 
China, HHV-8 could become a severe public health issue 
in the future.
According to data from the Xinjiang Uygur Autono-
mous Region, minority groups were at higher risk for HHV-
8 infection than the Han ethnic group. Although there was 
evidence for considerable heterogeneity among the studies, 
the association between ethnicity and HHV-8 risk showed 
that minorities were at higher risk for HHV-8 infection 
when compared with the Han ethnic group. The reasons 
behind this association are not well elucidated. Because all 
of the comparisons of HHV-8 difference between minor-
ity groups and the Han ethnic group are from the Xinjiang 
Uygur Autonomous Region, epidemiologic confi rmation 
of this observation would require data from other regions, 
which is currently unavailable. Our analysis showed a mar-
ginally signifi cant association between blood contact and 
HHV-8 infection; heterogeneity among studies was sub-
stantial. These data indicate that blood-borne transmission 
could occur among the Chinese population, a fi nding that is 
consistent with previous reports from other countries (11). 
This study has some limitations. The studies included 
in this meta-analysis were not evenly distributed through-
out China because information was not available from all 
the regions. Also, all of the studies might have used dif-
ferent methods for HHV-8 detection because of the lack 
of a standard assay; prevalence estimates may have been 
underestimated.
In summary, this meta-analysis clearly shows that 
the distribution of HHV-8 seroprevalence varies in China. 
The available information is still too limited to fully un-
derstand HHV-8 prevalence and the risk factors associated 
with transmission. Further studies are urgently needed to 
explore the epidemiology of HHV-8 infection in different 
subpopulations in China.
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Figure. Regional distribution of pooled human herpesvirus 
8 (HHV-8) prevalence in A) the general population and B) 
immunocompromised patients, China.
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